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Abstract
OBJECTIVES: Potassium-based depolarizing St Thomas’ Hospital cardioplegic solution No 2 administered as intermittent, oxygenated blood
is considered as a gold standard for myocardial protection during cardiac surgery. However, the alternative concept of polarizing arrest may
have beneficial protective effects. We hypothesize that polarized arrest with esmolol/adenosine/magnesium (St Thomas’ Hospital Polarizing
cardioplegic solution) in cold, intermittent oxygenated blood offers comparable myocardial protection in a clinically relevant animal model.
METHODS: Twenty anaesthetized young pigs, 42 ± 2 (standard deviation) kg on standardized tepid cardiopulmonary bypass (CPB) were ran-
domized (10 per group) to depolarizing or polarizing cardiac arrest for 60 min with cardioplegia administered in the aortic root every 20 min
as freshly mixed cold, intermittent, oxygenated blood. Global and local baseline and postoperative cardiac function 60, 120 and 180 min after
myocardial reperfusion was evaluated with pressure–conductance catheter and strain by Tissue Doppler Imaging. Regional tissue blood flow,
cleaved caspase-3 activity, GRK2 phosphorylation and mitochondrial function and ultrastructure were evaluated in myocardial tissue samples.
RESULTS: Left ventricular function and general haemodynamics did not differ between groups before CPB. Cardiac asystole was obtained and
maintained during aortic cross-clamping. Compared with baseline, heart rate was increased and left ventricular end-systolic and end-diastolic
pressures decreased in both groups after weaning. Cardiac index, systolic pressure and radial peak systolic strain did not differ between groups.
Contractility, evaluated as dP/dtmax, gradually increased from 120 to 180 min after declamping in animals with polarizing cardioplegia and was
significantly higher, 1871 ± 160 (standard error) mmHg/s, compared with standard potassium-based cardioplegic arrest, 1351 ± 70 mmHg/s,
after 180 min of reperfusion (P = 0.008). Radial peak ejection strain rate increased and the load-independent variable preload recruitable
stroke work was increased with polarizing cardioplegia after 180 min, 64 ± 3 vs 54 ± 2 mmHg (P = 0.018), indicating better preserved left
ventricular contractility with polarizing cardioplegia. Phosphorylation of GRK2 in myocardial tissue did not differ between groups. Fractional
cytoplasmic volume in myocytes was reduced in hearts arrested with polarizing cardioplegia, indicating reduction of cytoplasmic oedema.
CONCLUSIONS: Polarizing oxygenated blood cardioplegia with esmolol/adenosine/magnesium offers comparable myocardial protection and
improves contractility compared with the standard potassium-based depolarizing blood cardioplegia.
Keywords: Cardioplegia •Myocardial protection • Cardiac function • Animal model
INTRODUCTION
Over the past two decades, surgical treatment for cardiac disease
has occurred in patients that are more elderly and have more
complex disease. As a consequence, there is an increasing demand
for new perfusion strategies associated with prolonged duration of
cardiopulmonary bypass (CPB) and cardiac arrest that will provide
improved myocardial protection. Potassium-based depolarizing
cardioplegia, delivered as oxygenated cold blood, is a dominant
routine used worldwide [1]. A number of different techniques
for optimizing myocardial protection have been studied, both
†Presented at the 95th Annual Meeting of the American Association for
Thoracic Surgery, Seattle, WA, USA 25–29 April 2015.
© The Author 2016. Published by Oxford University Press on behalf of the European Association for Cardio-Thoracic Surgery. This is an Open Access article distributed
under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-
use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com.
European Journal of Cardio-Thoracic Surgery 50 (2016) 130–139 ORIGINAL ARTICLE
doi:10.1093/ejcts/ezv488 Advance Access publication 2 February 2016
experimentally and clinically. Polarizing cardioplegic protocols have
also been extensively studied [2]; the concept of polarized arrest has
shown that enhanced protection can be achieved [3]. A new
polarizing cardioplegic solution, the St Thomas’ Hospital Polarizing
cardioplegic solution (STH-POL), containing a mixture of the short-
acting β-adrenergic receptor blocker esmolol, adenosine and Mg2+,
has recently been suggested. The solution combines the inhibition
of fast Na+- and L-type Ca2+-channels of esmolol, the KATP-channel
opener effect of adenosine and the reduced myocardial Ca2+ load
caused by magnesium [3, 4]. Before implementation of a new tech-
nique for myocardial protection in clinical studies and practice, it
must be compared and found to be non-inferior or superior to the
current technique in a translational large animal in vivomodel.
In a standardized clinically relevant porcine model involving CPB,
we have investigated whether cardioplegic arrest with STH-POL offers
myocardial protection comparable with a standard depolarizing
potassium-based cardioplegic solution; both delivered as repeated,
cold, oxygenated blood cardioplegia. The main focus for the evalu-
ation was to compare the left ventricular global and local function up
to 3 h after aortic declamping, weaning and decannulation.
MATERIALS ANDMETHODS
Animals and anaesthesia
The experimental protocol was approved by the Norwegian State
Commission for Laboratory Animals (Project 20135835), and con-
ducted in accordance with the European Communities Council
Directive of 2010 (63/EU). The animals were brought to the animal
facility about 1 week in advance for acclimatization. Twenty-four
young pigs (Norwegian land race) of either gender, weighing 42 ± 2
[standard deviation (SD)] kg were used. After premedication with
intramuscular injection of a mixture of ketamine (20 mg/kg), diaze-
pam (10 mg) and atropine (1 mg), the pigs were ventilated spontan-
eously on mask for a short period with oxygen and 3% isoflurane
(Rhodia, Bristol, UK) allowing intravenous access through two ear
veins. Before tracheotomy and intubation, loading doses of intra-
venous fentanyl (0.02 mg/kg), midazolam (0.3 mg/kg), pancuro-
nium (0.063 mg/kg) and pentobarbital (15 mg/kg) were given, and
continuous infusions of fentanyl (0.02 mg/kg per h), midazolam
(0.3 mg/kg per h), pancuronium (0.2 mg/kg per h) and pentobar-
bital (4 mg/kg per h) were initialized. The animals were ventilated
( Julian, Drägerwerk, Lübeck, Germany) with a mixture of nitrous
oxide (56–58%) and oxygen. Prophylactic antibiotic therapy with
cefalotin 1 g (in 50 ml 0.9% NaCl) was given IV initially, followed by
0.5 g during CPB and 1.0 g after weaning. Fluid substitution,
Ringer’s acetate 15 ml/kg per h with 20 mmol/l KCl added, was
given throughout the experiment. In addition, Ringer’s acetate 5
ml/kg per h was provided after weaning from CPB. The anaesthetic
protocol has been thoroughly evaluated, allowing the use of neuro-
muscular blocking agents in young pigs [5].
Surgical protocol and instrumentation
The right femoral artery and vein were cannulated for blood sam-
pling and infusion by surgical cut-down in the groin. An early arterial
blood gas analysis determined the need for ventilator adjustments.
An open suprapubic cystotomy with insertion of a catheter drained
the urine bladder. Rectal temperature was monitored. Midline ster-
notomy and pericardiotomy was performed and heparin (125 IU/
kg) given IV to prevent clotting of catheters. A continuous cardiac
output catheter (CCO/EDV 177HF 75, Edwards Lifesciences, Inc.,
Irvine, CA, USA) was advanced from the left internal mammary vein
into the pulmonary artery for monitoring cardiac output, right
ventricular end-diastolic volume, central venous pressure (CVP) and
pulmonary artery pressure (PAP) (Vigilance II® and TruWave® trans-
ducers, Edwards Lifescience, Inc.). The aorta was cannulated proxim-
ally with a Millar microtip pressure catheter (Millar MPC-500,
Houston, TX, USA) through the left internal mammary artery. The
haemodynamic parameters were sampled in real time by a
16-channel Ponemah (ACQ-7700; Data Sciences International, St
Paul, MN, USA), digitized and later analysed (Ponemah Physiology
Platform v. 5.2, Data Sciences International). A dual-field conduct-
ance-pressure catheter (CA71083-PL, CDLeycom, Hengelo,
Netherlands) was inserted through the apex and into the left ven-
tricle with the distal part in position just above the aortic valve, veri-
fied by epicardial echocardiography (Vivid E9, GE Vingmed
Ultrasound, Horten, Norway). The catheter was connected to a
Sigma-M signal conditioner (CDLeycom). The left atrium was cannu-
lated by an infant feeding tube for microsphere injections and a
tape placed around the inferior vena cava for brief intermittent
dynamic preload reductions.
Cardiopulmonary bypass
CPB (Stöckert SIII, Munich, Germany) was set up with 1200 ml
Ringer’s acetate as prime in the circuit. After anticoagulation
with heparin 500 IU/kg, the brachiocephalic artery (EOPA 18 Fr,
Medtronic, Inc., Minneapolis, MN, USA) and right atrial appendage
(MC2 28/36 Fr, Medtronic Inc.) were cannulated, and CPB was estab-
lished with a flow of 90 ml/min per kg and water temperature of 32°
C in the heat exchanger. Aortic cross-clamp time was 60 min and a
left heart vent catheter (E061 17 Fr, Edwards Lifesciences, Inc.) was
placed through the left atrial appendage into the ventricle. The body
temperature was allowed to drift towards 34°C and the CPB flow was
reduced to 72 ml/min per kg when the rectal temperature reached
35°C or after 20 min. Rewarming was commenced after 40 min of
cross-clamping with reset of CPB flow to 90 ml/min per kg and
water temperature at 40°C. Arterial blood gases were obtained
before cross-clamping, after 30 min and just before declamping after
60 min. If ventricular fibrillation occurred after declamping, defibril-
lation was the only allowed antiarrhythmic intervention. All animals
were weaned from CPB at 10 min after declamping followed by
decannulation. The residual blood in the circuit was returned and
protamine sulphate 1 mg/kg was given for heparin reversal.
Cardioplegia
The animals were block-randomized to receive either hyperkalae-
mic cardioplegia based on a modification of St Thomas’ Hospital
cardioplegic solution No. 2 (STH-2), or cardioplegia containing the
short-acting β-adrenergic blocking agent esmolol, adenosine and
magnesium; St Thomas’ Hospital polarizing solution (STH-POL)
(Table 1). Both solutions were pre-prepared as concentrate and
administered as cold (12°C), oxygenated, blood cardioplegia,
freshly mixed and delivered by a dual-pump with separate cooling.
The cardioplegia was delivered into the aortic root with a flow set
to 7% of CPB flow, following a standardized protocol with an
initial ‘high-dose’ (1:4 concentrate/blood) for 3 min and 2 min of
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cross-clamping. The final concentrations of key components in the
two cardioplegic solutions are presented in Table 1.
Experimental protocol
After 10 min of stabilization, baseline variables were obtained;
arterial blood gases (ABL80 FLEX COOX, Radiometer Medical
ApS, Brønshøj, Denmark), s-troponin-T (Troponin-T hs®, Roche
Diagnostics, GmbH, Mannheim, Germany), haemodynamic vari-
ables and the first injection of 15-µm microspheres (Dye-Trak ‘F’;
Triton Technology, Inc., San Diego, CA, USA). After a short period
of ventilation with 100% oxygen, left ventricular pressure–volume
loops were registered with respirator shut-off in end-expirium
before and during a brief period of inferior vena cava occlusion. A
bolus of 5 ml hypertonic saline (10%) was injected into the pul-
monary artery and pressure volume loops were recorded in a
stable situation three times for estimation of parallel conductance
[6, 7]. Epicardial echocardiography was performed with a soft sili-
cone pad placed between the probe (6 MHz sector probe, GE
Vingmed Ultrasound) and the epicardium. During brief periods of
respiratory shut-off, pulsed wave Doppler (PWD) velocity spec-
trum recordings in the left aortic outflow tract were noted for
timing of end-systole and end-diastole. Tissue Doppler images
(TDIs) of the anterior left ventricular wall in short axis view were
recorded for radial strain and strain rate measurements.
At full CPB flow, an arterial blood gas was sampled followed by
aortic cross-clamping and cardioplegic arrest with STH-POL or
STH-2 given as cold blood cardioplegia. During CPB, the ventilator
volume was reduced to 50% and with passive drainage of the heart.
Additional heparin (250 IU/kg) was given at 30 min of cross-
clamping. After 60 min of cardioplegic arrest, the aortic clamp was
removed. The animals were weaned from CPB after 10 min of myo-
cardial reperfusion. General haemodynamics were continuously
recorded for 180 min. As for baseline, measurements of left ven-
tricular pressures, volumes, contractility, systolic and diastolic func-
tion, regional tissue blood flow and echocardiographic recordings
were repeated at 60, 120 and 180 min after aortic declamping.
Finally, the animal was euthanized with intracardiac injection of
high-dose potassium chloride, the heart removed and samples
were obtained for regional tissue blood flow measurements, ana-
lysis of mitochondrial ultrastructure and mitochondrial fatty acid
oxidation capacity, phosphorylated GRK2, Caspase-3 activity and
tissue water content.
Pressure–conductance catheter
Data from the pressure-conductance catheter were analysed with a
custom-made programme. The mean of 5–8 cardiac cycles during
the stable condition and load-independent variables obtained
during the dynamic preload reduction were calculated. Absolute
volumes were estimated by correcting for parallel conductance and
cardiac output. Volumes were indexed by body surface area (BSA)
calculated as BSA (m2) = (BW2/3 × k)/100 where BW is body weight
in kg and k for pigs is 9 m2/kg−2/3 [8].
Epicardial echocardiography
Local myocardial function (TDI strain and strain rate) in the anter-
ior wall was recorded. Peak systolic strain and peak ejection strain
rate were measured with commercial software (EchoPack BT12,
GE Vingmed Ultrasound). The size of the region of interest (ROI)
was set to 6 × 6 mm and the strain length (SL) to 6 mm. Care was
taken not to place the ROIs within a distance of ½SL from the
epicardium and ½SL from the endocardium [9]. End-diastole was
defined as the first deflection in the QRS complex in the ECG, and
start of ejection was defined at the aortic valve opening and end-
systole was defined as the time of aortic valve closure from the
PWD recording. The mean frame rate for the TDI recordings was
544 ± 78 (SD) frames/s (range 249–696).
Myocardial tissue samples and analyses
Multiple biopsies were obtained from the LV endo-, mid- and
epicardium, snap-frozen in liquid nitrogen and stored at −80°C for
later analysis. Caspase-3 activity was determined using the
Caspase-3 Colorimetric Assay Kit (BioVision, Inc., Milpitas, CA,
USA). Tissue was homogenized and lysis performed according to
the manufacturer’s instructions, and triplet samples containing 400
µg total protein, measured by the Quick Start™ Bradford Protein
Assay (Bio-Rad Laboratories, Inc., Hercules, CA, USA), were incu-
bated for 2 h before fluorometric readings. The activation of
G-protein-coupled receptor kinase 2 (GRK2) in the myocardium
was assessed with immunoblotting using antibodies against phos-
phorylated GRK2 (LS-C199027, LifeSpan BioSciences Inc., Seattle,
WA, USA) and total GRK2 (CST3982, Cell Signaling, Boston, MA,
USA) according to manufacturer’s instructions. The blots were
quantified using scanning densitometry. Mitochondrial carnitine
palmitoyltransferase I and II (CPT-I, CPT-II) activity in the outer and
inner mitochondrial membranes were measured in frozen myocar-
dial tissue samples. Each sample was homogenized after adding
500 µl of ice-cold sucrose (0.25 M sucrose, 5 mM HEPES-buffer,
0.2 mM ethylene glycol tetraacetic acid, pH 7.4) and centrifuged at
4°C, 600 g for 12 min. The protein concentration in the supernatant
(post-nuclear fraction) was measured (Bio-Rad Protein Assay,
Bio-Rad Laboratories, Inc.). In 150 µg of protein, CPT-I and CPT-II
were measured as earlier described [10]. In addition, corresponding
biopsies were obtained and fixed overnight in 0.1 M Na-cacodylate
buffer with 2.5% glutaraldehyde, washed, post-fixated with 1%
OsO4, dehydrated and stored in 70% ethanol, sectioned and
stained with uranyl acetate for the analysis of myocardial ultrastruc-
ture with electron microscopy. From six randomly selected sections,
images (×15 000) were obtained from the mid-myocardium,
myocyte volume fractions of mitochondria, myofibrils and sarco-
plasma were calculated by point counting. The mitochondrial











Esmolol (mM) 1.35 0.68 – –
Adenosine (mM) 0.50 0.25 – –
Mg2+ (mM) 20 10 16 9
K+ (mM) 4.3 4.3 22 14
Cl− (mM) 106 106 134 120
Procaine HCl (mM) 0.8 0.4 0.8 0.4
STH-POL: St Thomas’ Hospital Polarizing cardioplegic solution;
STH-2: Modified St Thomas’ Hospital cardioplegic solution No. 2.
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surface density and surface-to-volume ratio were calculated by a
Merz grid using the ImageJ freeware [11, 12]. Tissues obtained from
the left and the right ventricle were weighed, hydrolysed, micro-
spheres isolated by filtration, colours dissolved and quantified by
fluorospectrophotometry together with the reference blood
samples. Blood flow rate was calculated as earlier described [13].
Myocardial tissue water content was calculated as a fraction of wet
weight after drying samples for 3 weeks at 60°C.
Statistical analysis
Data were analysed by using SPSS v. 22 (SPSS, Inc., Chicago, IL, USA)
and values given as mean ± (SE) or median (25% quartile; 75% quar-
tile) unless otherwise noted. Baseline variables were compared by
two-sample Student’s t-test on data with normal distribution and
with Wilcoxon–Mann–Whitney U-test on ranks if the Kolmogorov–
Smirnov test or the Levene equal variance tests were significant.
Variables obtained during and after CPB were analysed separately
by two-way analysis of variance (ANOVA) for repeated measure-
ment (RM-ANOVA) with time as within factor (Pw) and cardioplegia
with STH-POL or STH-2 as grouping factor (Pg) and post hoc
Bonferroni contrasts between individual group means. If Mauchly’s
test of sphericity was significant (P < 0.05), the Greenhouse–Geisser
adjustment of degrees of freedom was selected for the evaluation
of main effects. For Caspase-3 activity and estimation of GRK2, wall
layers were set as related variables. If a significant interaction
(Pi < 0.10) effect was found, new ANOVAs for simple main effect
were performed with adjustment of degrees of freedom. Cell
means were finally compared with Neumann–Keuls multiple con-
trast tests when justified by the preceding ANOVA. The morpho-
logical variables were analysed with a nested ANOVA. P < 0.05 was
considered statistically significant.
RESULTS
Group characteristics at baseline and during
cardiopulmonary bypass
Four animals were excluded due to reasons other than technical
failure: two in the STH-POL group developed severe pulmonary
hypertension and arterial hypoxia with heart failure during baseline
measurements before allocation to treatment groups; two in the
STH-2 group, one due to severe pulmonary hypertension during
instrumentation before CPB and one due to persistent ventricular
fibrillation after declamping. Excluded animals were replaced by
consecutive experiments and the results are given for 10 animals in
each group. Baseline variables describing left and right ventricular
function, general haemodynamics, tissue blood flow rate, arterial
blood gases and serum troponin-T did not differ between groups
(Table 2, Figs 1–3).
The myocardial contraction rapidly ceased after aortic cross-
clamping and start of the cardioplegic infusion, with the median
time being 28 (11; 43) s for STH-POL and 22 (18; 27) s for STH-2
group (P = 0.79). During CPB, haemoglobin levels and serum-
potassium were moderately, but significantly increased in the
STH-2 group compared with the STH-POL group at 30 and 60 min
(see Supplementary Material). There were no differences between
the groups regarding mean arterial pressure, temperature and
arterial blood gases during CPB.
Cardiac and haemodynamic variables after
declamping
Heart rate was increased and left ventricular systolic (LVSP) and dia-
stolic (LVEDP) pressures decreased with time in both groups after
weaning from CPB (Fig. 1). Cardiac index (CI) increased during the
first hour after declamping in both groups, but then decreased slight-
ly but staying above baseline levels during the remaining 120 min of
reperfusion (Pw = 0.024). There were no significant differences
between the groups. In the STH-POL group, the first derivative of the
left ventricular pressure (LV-dP/dtmax) increased from 120 to 180
min of reperfusion, reaching values significantly higher than the
STH-2 group after 165 and 180 min of reperfusion. LV-dP/dtmin was
more negative in the STH-POL group after 180 min. There was a sig-
nificant difference between groups for indexed stroke work (SWi)
and for the load-independent contractility variable preload recruit-
able stroke work (PRSW) at 180 min after declamping (Fig. 2).
Ejection fraction and the slope of the end-systolic pressure–volume
relationship (ESPVRslope) did not differ between groups, neither did
the isovolumic relaxation constant Tau nor the left ventricular
compliance β. Whereas radial peak systolic strain in the anterior left
ventricular wall decreased significantly over time in both groups
(Pw = 0.004), radial peak ejection strain rate decreased in the STH-2
group to values significantly lower than in the STH-POL group at
180 min (Fig. 3). There was a significant decrease over time in
indexed left ventricular stroke volume (LV-SVi) and a decrease in
Table 2: Baseline variables before cardiac arrest with
polarizing (STH-POL) and depolarizing (STH-2) cardioplegia
Variable STH-POL STH-2 Statistics
LV-EDVi (ml/m
2) 83 ± 5 78 ± 4 P = 0.50
LV-ESVi (ml/m
2) 41 ± 4 35 ± 4 P = 0.28
LV-SVi (ml/m
2) 50 ± 3 51 ± 2 P = 0.72
RV-EDVi (ml/m
2) 136 ± 4 148 ± 7 P = 0.16
RV-EF (%) 24 ± 1 26 ± 1 P = 0.28
MAP (mmHg) 95 ± 4 96 ± 3 P = 0.77
CVPmean (mmHg) 5.8 ± 0.5 6.2 ± 0.5 P = 0.58
PAPmean (mmHg) 18.8 (15.5; 21.8) 19.6 (18.3; 20.4) P = 0.47
LV blood flow
(ml/min per g)
0.92 ± 0.05 1.04 ± 0.06 P = 0.16
RV blood flow
(ml/min per g)
0.68 ± 0.07 0.83 ± 0.05 P = 0.14
Arterial blood gases
pH 7.51 (7.49; 7.52) 7.52 (7.51; 7.53) P = 0.25
pCO2 (kPa) 5.2 ± 0.1 5.02 ± 0.1 P = 0.24
HCO3
− (mmol/l) 31.2 ± 0.2 31.2 ± 0.4 P = 0.95
BE (mmol/l) 7.3 ± 0.2 7.2 ± 0.4 P = 0.89
pO2 (kPa) 25.8 ± 0.8 25.6 ± 0.5 P = 0.88
Hb (g/dl) 8.2 ± 0.2 8.1 ± 0.2 P = 0.64
Hct (%) 25.6 ± 0.5 25.2 ± 0.6 P = 0.64
s-Na+ (mmol/l) 142 (140; 143) 142 (141; 143) P = 0.94
s-K+ (mmol/l) 3.7 ± 0.1 3.7 ± 0.1 P = 0.59
s-Cl− (mmol/l) 103.1 ± 0.9 103.4 ± 0.6 P = 0.78
s-Troponin-T
(µmol/l)
47.6 ± 4.7 53.4 ± 6.5 P = 0.48
Values are mean ± SE or median (25-percentile; 75-percentile), n = 10.
LV and RV: left and right ventricle; i: value indexed for body surface
area; EDV: end-diastolic volume; ESV: end-systolic volume; SV: stroke
volume; MAP: mean arterial pressure; CVPmean: mean central venous
pressure; PAPmean: mean pulmonary artery pressure; STH-POL: St
Thomas’ Hospital Polarizing cardioplegic solution; STH-2: St Thomas’
Hospital cardioplegic solution No. 2; SE: standard error.
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right ventricular end-diastolic volume (RV-EDVi) for both groups
(Table 3). The mean aortic blood pressure (MAP) was unchanged in
the STH-POL group and decreased over time in the STH-2 group
with a significant difference between groups at 180 min of reperfu-
sion. The mean PAP was unchanged and CVP slightly increased over
time in both groups (Pw = 0.003). Regional tissue blood flow rate in
the left and the right ventricular wall was unchanged from 60 to 180
min of reperfusion. Left ventricular tissue water content averaged
80.1 ± 0.1% (n = 20), with no group difference. Serum troponin-T
levels did not differ between groups at 180 min after declamping;
median values were 504 (328; 886) µmol/l in the STH-POL group
and 580 (401; 717) µmol/l in the STH-2 group (P = 0.73).
Myocardial apoptosis and β-receptor activity
There was no difference between groups in myocardial apoptotic
activation evaluated as cleaved caspase-3 activity (Pg = 0.84) (Fig. 4).
In the subepicardium, cleaved caspase-3 activity was increased
in both groups compared with that in the mid-myocardial and
subendocardial wall layers (Player = 0.024). Phosphorylation of GRK2
(relative to tissue from control heart) in the mid-myocardial wall
layers was increased in both groups compared with levels in the
subendo- and subepicardial wall layers (Player = 0.001). The total
GRK2 content did not differ between wall layers or between
groups.
Figure 1: Baseline left ventricular haemodynamic variables mean (SE) or median (25%; 75%), and values obtained after CPB and 60 min of cardiac arrest with polariz-
ing (STH-POL) and depolarizing (STH-2) cardioplegia. Bars represent SE. Pw, Pg and Pi: P-values for within subjects, between groups and interaction from two-way
RM-ANOVA, respectively; #Significantly different from STH-POL at 180 min of reperfusion with Bonferroni post hoc test. SE: standard error of the mean; CPB: cardio-
pulmonary bypass; RM-ANOVA: analysis of variance for repeated measurement; CI: Cardiac Index; LVSP: left ventricular peak systolic pressure; LVEDP: left ventricular
peak end-diastolic pressures; dP/dtmax and dP/dtmin: peak positive and peak negative of the first derivative of left ventricular pressure.
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Mitochondrial ultrastructure and metabolism
In the mid-myocardium, there was a significant increase in the
volume fraction of the sarcoplasma resulting in a concomitant de-
crease in the volume fraction of myofibrils in the STH-2 group
(Fig. 5). The volume fraction of mitochondria did not differ signifi-
cantly. Furthermore, the surface density of the mitochondria did
not differ between groups. The surface-to-volume ratio was slight-
ly decreased for the STH-POL group, indicating mitochondrial
swelling. The carnitine transport systems for long chain fatty acids,
evaluated as CPT-I and CPT-II activity, were not affected by the
selection of the cardioplegic protocol.
DISCUSSION
This study provides evidence that ‘polarised’ arrest with a solution
containing a mixture of esmolol, adenosine and magnesium in
oxygenated blood offers myocardial protection that is comparable
with standard potassium-based (depolarised) cold, intermittent
Figure 2: Left ventricle functional variables at baseline and 60, 120 and 180 min after CPB and aortic declamping following cardiac arrest with polarizing (STH-POL)
and depolarizing (STH-2) cardioplegia. Mean or median values, bars are SE or 25 and 75 percentiles. Statistics as in Fig. 1. #Significantly different from STH-POL at 180
min of reperfusion, *Significantly different from 60 min of reperfusion within STH-2 group. EF: ejection fraction; SWi: indexed stroke work; PRSW: slope of preload re-
cruitable stroke work; ESPVRslope: slope of the end-systolic pressure volume relationship; Tau: isovolumic relaxation constant; β: the logarithmic end-diastolic pressure
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oxygenated blood cardioplegia in a clinically relevant porcine
model. At 180 min after aortic declamping, left ventricular con-
tractile function evaluated as LV-dP/dtmax, PRSW and peak ejec-
tion strain rate was better maintained in animals with polarizing
compared with depolarizing cardioplegic arrest for 60 min.
Furthermore, the hearts arrested with polarizing cardioplegia gen-
erate an increased systemic blood pressure (MAP) 180 min after
declamping. This could be a result of reduced development of left
ventricular myocardial stunning in the STH-POL group 3 h after
declamping. Troponin-T release and the degree of apoptosis did
not differ and contradict differences in irreversible myocardial
damage between groups. The increase in variables describing
contractility such as PRSW, LV-dP/dtmax and strain rate in the
STH-POL group 180 min after declamping is not a result of activa-
tion of the Frank–Starling mechanism in the left ventricle. The left
ventricular end-diastolic volume was unchanged and did not
differ between groups (Table 3). Similarly, the load-dependent
variables of left ventricular EF (Fig. 2) and radial TDI strain (Fig. 3)
were not different between groups during the 180 min of obser-
vation after declamping. Group differences in LV-dP/dtmax and
strain rate could be affected by the differences in heart rate.
However, heart rate did not differ between groups after declamp-
ing (Fig. 1). The increased contractility did not improve cardiac
function evaluated by LV-EF and Cardiac Index. The increased
indexed stroke works at 180 min in the STH-POL group, potential-
ly resulting from slight, but non-significant increases in LVSP and
CI, indicate that left ventricle performance was improved follow-
ing polarizing cardioplegic arrest in the present study. This in-
crease in left ventricular workload was not reflected in a
substantial increase in left ventricular tissue blood flow rate. We
interpret these results due to an improvement in myocardial pro-
tective efficacy with polarised cardioplegic arrest, possibly due to
a reduced ionic inhomogeneity and consequently reduced energy
utilization [3].
In chronic heart failure, increased catecholamine release with
impaired signalling and desensitization of β-adrenergic receptors
(β-AR) contributes to myocardial dysfunction [14]. During CPB and
cardioplegic arrest, serum catecholamines increase and norepin-
ephrine is released locally from the hypothermic and anoxic myo-
cardium [15, 16]. This can lead to β-AR desensitization and is
associated with increased GRK2 activity. Hence, β-AR desensitiza-
tion and increased GRK2 activity may explain several aspects of
the myocardial stunning observed after cardiac surgery [17]. The
addition of esmolol systemically during CPB in dog hearts subse-
quently arrested with potassium-based crystalloid cardioplegia
demonstrated enhanced β-adrenergic receptor signalling with
improved postischaemic function [18]. Similarly, the addition of
esmolol before CPB in pigs arrested with cold potassium-based
blood cardioplegia improved late contractile function [19].
Interestingly, the addition of esmolol to cold potassium-based
blood cardioplegia was also able to enhance late myocardial re-
covery of function in pigs subjected to CPB and 100 min of ischae-
mic arrest [20]. As indicated by the tissue levels of phosphorylated
GRK2 in the present study, there is no evidence for altered GRK2
activity in either group (Fig. 4). Since neither adenylate cyclase ac-
tivity nor GRK2 activity was measured directly, the prevention of
β-receptor desensitization could not be completely ruled out as
an explanation for the improved contractile function observed in
animals with polarizing cardioplegia (Figs 1–3).
The administration of repeated oxygenated blood cardioplegia
during cardiac surgery implies multiple episodes of ischaemia and
re-oxygenation before the final declamping and reperfusion.
Beta-receptor blockade during cardioplegic arrest is of potential
interest for reducing both ischaemic- and lethal reperfusion injury.
However, the unwanted negative inotropic effect during reperfu-
sion and weaning could be potentially harmful, especially if the
β-blocking agent has a prolonged half-life. Esmolol is rapidly meta-
bolized by blood esterase and has a half-life of 9 min [21].
Esmolol has been found beneficial as an alternative to cardioplegia
by inducing ‘minimal myocardial contraction’ [22], or as a supple-
ment to standard cardioplegic regimes [19, 20]. In the present study,
there was a trend towards an early but transient reduction in heart
rate as well as a significantly higher LVEDP at 20 min after declamp-
ing (Fig. 1), indicating a residual negative chronotropic and inotrop-
ic effect of esmolol early after declamping. However, by 30 min
after declamping, these negative effects were abolished.
Myocardial ischaemic injury and lethal reperfusion injury are
reduced by β-adrenergic blockers and the modulation of apoptot-
ic cell death is also linked to β-receptor adrenergic signalling and
GRK2 activation [23]. In the present study, neither release of
troponin-T at 180 min after aortic declamping nor activation of
apoptotic activity ( judged by tissue cleaved caspase-3 activity) dif-
fered between treatment groups.
In research and in clinical practice, different forms of cardioplegic
solutions delivered as crystalloid or as blood-based cardioplegia
Figure 3: (A) Radial peak systolic TDI strain and (B) peak ejection strain rate at
baseline and 60, 120 and 180 min after CPB and aortic declamping in the left
ventricular anterior wall following cardiac arrest with polarizing (STH-POL) and
depolarizing (STH-2) cardioplegia. Mean values, bars are SE. #Significantly dif-
ferent from STH-POL at 180 min of reperfusion. Statistics as in Fig. 1. SE: stand-
ard error; RM-ANOVA: analysis of variance for repeated measurements.
T. Aass et al. / European Journal of Cardio-Thoracic Surgery136
have been studied and are in use. Both intracellular solutions with
amino acids as buffer and low levels of Na+ and Ca2+, and extracellu-
lar solutions with normal levels of Na+ and Ca2+ rely on moderately
increased concentrations of potassium to obtain cardiac arrest [1].
Potassium-based depolarizing cardioplegia inactivates the fast Na+
channel in the myocyte membrane, by inducing re-equilibration of
the membrane potential to a more positive level and thereby pre-
venting the voltage-activated Na+ spike of the action potential and
the triggering of contraction [3]. This, together with myocardial
cooling, reduces energy consumption and oxygen demands during
cardiac arrest. At this re-equilibrated membrane potential, the non-
inactivating Na+ current leads to increases in intracellular Na+, with
subsequent reversal of the Na+/Ca2+-exchanger; the resultant Na+
and Ca2+ overload is potentially harmful. Increased tissue oedema in
hearts arrested with the hyperkalaemic STH-2 cardioplegia was
found compared with the normokalaemic STH-POL cardioplegia,
and this is consistent with previous findings [22]. In contrast, esmolol
inhibits the fast Na+-channels and the L-type Ca2+-channels [4]; ad-
enosine is a KATP-channel opener and magnesium is an endogenous
Ca2+-channel blocker. These pharmacological effects will reduce
the ionic heterogeneity that occurs during ischaemia and will con-
comitantly reduce high-energy phosphate utilization. Adenosine
induces hyperpolarized cardiac arrest in normokalaemic cardiople-
gic solutions, and also in a clinical setting [24]. Magnesium is a com-
ponent of STH-2 cardioplegia, exerting an anti-ischaemic protective
effect. However, the efficacy of magnesium as adjuvant to cardiople-
gic solutions has been questioned [25]. One could therefore specu-
late if esmolol and adenosine alone could be an alternative
polarizing cardioplegic solution.
Limitations
In addition to the obvious possibility of species differences, the
present study is performed in healthy young hearts without coron-
ary pathology where the conditions for myocardial protection are
optimized. In addition, the limited cross-clamp time and the total
potassium load in the present study could obscure possible advan-
tages with polarizing cardioplegic arrest. Furthermore, an increase
in both ischaemic time connected to more complex surgical proce-
dures and prolonged observation time after declamping could
more precisely clarify such differences. Also, intermittent STH-POL
cardioplegia should be compared with other routines, for instance
with solutions designed for single-shot administration.
Table 3: Cardiac and haemodynamic variables and tissue blood flow 60, 120 and 180 min after aortic declamping following 60
min of polarizing (STH-POL) or depolarizing (STH-2) cardioplegic arrest
Variable 60 min (A) 120 min (B) 180 min (C) RM-ANOVA statistics
LV-EDVi (ml/m
2)
STH-POL 60 ± 3 59 ± 4 54 ± 2 Pw = 0.26, Pg = 0.55, Pi = 0.92
STH-2 64 ± 4 60 ± 6 58 ± 4
LV-ESVi (ml/m
2)
STH-POL 23 ± 2 28 ± 4 22 ± 2 Pw = 0.54, Pg = 0.36, Pi = 0.53
STH-2 27 ± 3 29 ± 4 30 ± 7
LV-SVi (ml/m
2)
STH-POL 42 ± 2 37 ± 2 37 ± 1 Pw < 0.001, Pg = 0.22, Pi = 0.51
STH-2 42 ± 3 37 ± 4 34 ± 3
RV-EDVi (ml/m
2)
STH-POL 134 ± 5 128 ± 4 123 ± 3 Pw = 0.006, Pg = 0.55, Pi = 0.73
STH-2 142 ± 6 132 ± 4 130 ± 5
RV-EF (%)
STH-POL 30 ± 2 28 ± 1 31 ± 2 Pw = 0.162, Pg = 0.32, Pi = 0.35
STH-2 30 ± 2 26 ± 1 27 ± 2
MAP (mmHg)
STH-POL 72 ± 4 71 ± 4 74 ± 4 Pw = 0.127, Pg = 0.31, Pi = 0.046
STH-2 73 ± 3 67 ± 4 63 ± 3a,#
CVP (mmHg)
STH-POL 8.0 ± 0.7 8.1 ± 0.8 9.3 ± 0.9 Pw = 0.003, Pg = 0.57, Pi = 0.85
STH-2 8.4 ± 0.7 8.9 ± 0.8 10.1 ± 1.1
PAP (mmHg)
STH-POL 24 ± 1 24 ± 2 25 ± 1 Pw = 0.30, Pg = 0.12, Pi = 0.63
STH-2 26 ± 2 28 ± 2 28 ± 2
LV blood flow (ml/min per g)
STH-POL 1.39 ± 0.15 1.24 ± 0.10 1.36 ± 0.10 Pw = 0.16, Pg = 0.46, Pi = 0.69
STH-2 1.32 ± 0.08 1.19 ± 0.06 1.21 ± 0.09
RV blood flow (ml/min per g)
STH-POL 1.53 ± 0.21 1.27 ± 0.10 1.30 ± 0.09 Pw = 0.073, Pg = 0.58, Pi = 0.92
STH-2 1.60 ± 0.17 1.34 ± 0.08 1.42 ± 0.17
Values are mean ± SE for 10 animals in each group.
LV and RV: left and right ventricle; i: value indexed for body surface area; EDV: end-diastolic volume; ESV: end-systolic volume; SV: stroke volume; MAP: mean
arterial pressure; CVP: mean central venous pressure; PAP: mean pulmonary artery pressure; STH-POL: St Thomas’ Hospital polarizing cardioplegic solution;
STH-2: St Thomas’ Hospital cardioplegic solution No. 2; RM-ANOVA: analysis of variance for repeated measurement.
Pw, Pg and Pi: P-values for within subjects, between groups and interaction from two-way RM-ANOVA, respectively.
aSignificant difference within group means from value(s) in columns with corresponding capital letters.
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Clinical implications
On the basis of the present study, polarizing cardioplegia with
esmolol, adenosine and magnesium seems non-inferior to stand-
ard depolarizing, potassium-based repeated, oxygenated blood
cardioplegia. Clinical research protocols could be initiated, at least
in patients requiring a short-to-medium time of cardiac arrest
during heart surgery.
CONCLUSIONS
This translational large animal study demonstrates that polarizing
oxygenated blood cardioplegia with esmolol/adenosine/magnesium
offers comparable myocardial protection and improves contractility
Figure 5: (A) Mid-myocardial myocyte volume fractions, (B) mitochondrial
surface density (SVMi), surface-to-volume ratio (SVratioMi) and (C) carnitine pal-
mitoyltransferase activity in the outer (CPT-I) and inner (CPT-II) mitochondrial
membrane. Bars are mean + SE. Pg is the probability by two-sample t-tests. SE:
standard error.
Figure 4: (A) Caspase-3 activity (n = 10 + 9), (B) phosphorylated (Phospho-GRK2)
and (C) total (GRK2total) G protein-coupled receptor kinase-2) (n = 9 + 9) in myo-
cardial tissue samples obtained 180 min after reperfusion following CPB and 60
min of cardioplegic arrest with polarizing (STH-POL) and depolarizing (STH-2)
cardioplegia. Bars are mean + SE. Statistics as in Fig. 1. SE: standard error;
RM-ANOVA: analysis of variance for repeated measurements.
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compared with the standard potassium-based depolarizing blood
cardioplegia.
SUPPLEMENTARY MATERIAL
Supplementary material is available at EJCTS online.
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